Litcius/Paper detail

Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis

Mingbo Cao, Yuxuan Li, Xiaoping Su, Yongchang Tang, Yupeng Ren, Jing Luo, Feng Yuan, Gaoyuan Yang, Zhiwei He, Zheng Shi, Ziyi Hu, Guirong Liang, Qi Zhang, Meihai Deng, Zhicheng Yao, Nan Lin

2025Drug Resistance Updates8 citationsDOI

Topics & Concepts

ExosomeHepatocellular carcinomaCancer researchLenvatinibCell biologyCytoskeletonMicrovesiclesChemistryMedicineBiologymicroRNACellGeneBiochemistrySorafenibGalectins and Cancer BiologyRNA modifications and cancerCircular RNAs in diseases